Diabetes (DM) Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Diabetes (DM) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Community Health Workers Led Integrated Management of Hypertension and Diabetes in Nepal

Diabetes (DM)Hypertension (HTN)
Kathmandu University School of Medical Sciences398 enrolled1 locationNCT07432126
Recruiting
Phase 1Phase 2

Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes

Diabetes (DM)Diabetic KetoacidosisKetosis Prone Diabetes+1 more
David K Carroll60 enrolled1 locationNCT07167693
Recruiting

Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy

Diabetic Retinopathy (DR)Diabetic Retinopathy Associated With Type 2 Diabetes MellitusDiabetes (DM)+1 more
Sara A Belal70 enrolled1 locationNCT07351786
Recruiting

The Force Frequency Relationship in Heart Failure and Diabetes Mellitus: a Metabolic Aetiology?

Heart FailureDiabetes (DM)
University of Leeds160 enrolled1 locationNCT07309523
Recruiting

Dietitian-Nutritionist vs. Day Hospital in the Metabolic Control of Patients With Type 2 Diabetes

Diabetes (DM)
Consorci Sanitari de l'Alt Penedès i Garraf140 enrolled1 locationNCT07285330
Recruiting

Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups

Depression - Major Depressive DisorderAnorexia NervosaBulimia Nervosa+17 more
Forschungsinstitut der Diabetes Akademie Mergentheim1,809 enrolled3 locationsNCT07212075
Recruiting

Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients

Diabetes (DM)SGLT2-InhibitorsCKD - Chronic Kidney Disease+1 more
Grigore T. Popa University of Medicine and Pharmacy200 enrolled1 locationNCT07237451